The investment from the Development Bank of Wales and regional angels will fund platform development and customer acquisition.
"We are delighted to secure Development Bank of Wales as an investor. This investment will be used to develop our technology platform and recruit more customers to our service."
The funding will support the implementation of specialised screening technology aimed at identifying rare diseases earlier in the patient journey.
"We are delighted to support Mendelian as part of our work into rare diseases. With over 3 million rare disease patients in the UK, innovative technologies using data analytics and machine learning like this are increasingly vital in ensuring that these conditions are diagnosed earlier to provide more targeted and personalised treatment for patients."
The healthcare analytics firm raised the venture funding from Guinness EIS Funds to scale operations and enhance its artificial intelligence capabilities.
"our software platform business has been accelerating significant recently and so we are raising capital to scale the business through increased penetration of our existing customers and territories, as well as converting our expanding pipeline of new prospects. We have tripled our AI and ML investment over the last year through a number of long-term projects with existing customers. Our strategy continues to focus on real value creation with better outcomes for healthcare providers and their patients. As outcomes, efficiency and patient flow becomes more of a challenge globally, I’m fortunate to lead a team of people who are all dedicated to advancing the capabilities of data analytics in healthcare and improving care delivery."
Leading healthcare technology investors join the round to support global expansion and service development.
"We are delighted to have been able to close this latest round of funding with TTCP and MSD GHI. Not only because it enables us to expedite our growth but, strategically, we now have two further partners whose business is all about innovation."
The funding was led by the Development Bank of Wales to support the commercial launch of the Podium device.
"Detecting diabetic foot complications as early as possible is crucial as people with diabetes could suffer from a loss of feeling in their feet, which can lead to foot ulcers which increases the risk of amputation. Once a patient has received an amputation, their quality of life is impacted. More worryingly, life expectancy is 5 years post-amputation, on average."